Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esmolol versus remifentanil during laparoscopic gastric bypass surgery
2014-003713-28Phase 4Completed
- Sponsor
- University Hospital Örebro
- Start
- Sep 2014
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of esmolol, remifentanil and morphine in obesity (2 arms), sponsored by University Hospital Örebro. Primary endpoint: Cumulative consumption of morphine at 2 hours post-operative. Started Sep 2014; status: completed.
02
Drugs
esmololremifentanilmorphine
03
Conditions
obesity
Beyond the preview
Go deeper on 2014-003713-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-003713-28.